Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.

Optiscan Imaging Ltd is primarily present in Australia.

Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.

Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.

The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.

Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.

The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.

Το Optiscan Imaging P/E είναι -25,80.

Το KUV της εταιρείας Optiscan Imaging είναι 135,31.

Το AlleAktien Qualitätsscore για το Optiscan Imaging είναι 7/10.

Ο κύκλος εργασιών του Optiscan Imaging είναι 1,16 Εκ. AUD.

Το Optiscan Imaging κέρδος είναι -6,06 Εκ. AUD.

Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.

Η Optiscan Imaging καταβάλλει μια διανομή της τάξεως των 0 AUD διαμοιρασμένη σε δόσεις ετησίως.

Το μέρισμα δεν μπορεί να υπολογιστεί για το Optiscan Imaging αυτή τη στιγμή ή η εταιρεία δεν διανέμει μέρισμα.

Ο αριθμός ISIN της Optiscan Imaging είναι AU000000OIL4.

Το WKN της Optiscan Imaging είναι 932111.

Ο τίκερ της Optiscan Imaging είναι OIL.AX.

Κατά τους τελευταίους 12 μήνες η Optiscan Imaging κατέβαλε μια μέρισμα ύψους . Αυτό αντιστοιχεί σε απόδοση μερίσματος περίπου . Για τους επόμενους 12 μήνες, η Optiscan Imaging προβλέπεται να πληρώσει μέρισμα 0 AUD.

Η απόδοση μερίσματος της Optiscan Imaging ανέρχεται σήμερα στο .

Optiscan Imaging πληρώνει τέταρτον διανεμητέου μισθό. Αυτή καταβάλλεται τους μήνες .

Η Optiscan Imaging πλήρωσε κάθε χρόνο μέρισμα μέσα στα τελευταία 0 έτη.

Για τους επόμενους 12 μήνες αναμένονται μερίσματα σε ύψος των 0 AUD. Αυτό αντιστοιχεί σε απόδοση μερίσματος 0 %.

Το Optiscan Imaging ανατίθεται στον τομέα 'Υγεία'.

Για να λάβεις το τελευταίο μέρισμα των Optiscan Imaging από την 30/9/2024 με τιμή 0 AUD, έπρεπε να έχεις τη μετοχή στο χαρτοφυλάκιο σου πριν από την ημέρα Ex-Tag στις 30/9/2024.

Η τελευταία μερίσματος έγινε στις 30/9/2024.

Το έτος 2023, η Optiscan Imaging διένειμε 0 AUD ως μερίσματα.

Τα μερίσματα του Optiscan Imaging καταβάλλονται σε AUD.